Choroidal collateral vessels typical of moyamoya disease have received attention as a potential bleeding source. The authors’ previous angiographic cross-sectional analysis suggested a possible association between choroidal collaterals and posterior hemorrhage, indicating a high risk for rebleeding. The present longitudinal analysis is intended to determine whether choroidal collaterals are a predictor of rebleeding in hemorrhagic moyamoya disease.
The Japan Adult Moyamoya Trial group designed an ancillary cohort study using 5-year follow-up data on 37 patients included in the nonsurgical arm of the original randomized controlled trial and compared the rebleeding rate of those with and those without choroidal collaterals, represented by the connection between the anterior or posterior choroidal arteries and the medullary arteries. An expert panel determined whether a choroidal collateral was present in each patient through the measurement of baseline angiography studies. The rebleeding rate comparison was adjusted for age, diagnosis of hypertension, and involvement of the posterior cerebral artery.
Choroidal collaterals were present in 21 patients (56.8%). The rebleeding rate was 13.1% per year in the collateral-positive group as compared with 1.3% in the negative group (p = 0.008, log-rank test). The adjusted hazard ratio for rebleeding in the collateral-positive group relative to the negative group remained statistically significant (HR 11.10, 95% CI 1.37–89.91). Radiographic assessment of the collateral-positive group revealed good correspondence between the distribution of collaterals and rebleeding sites.
Results of this study suggest that choroidal collaterals are a bleeding source with a high risk for hemorrhagic recurrence and a predictor of rebleeding in hemorrhagic moyamoya disease.
ABBREVIATIONSHR = hazard ratio; JAM = Japan Adult Moyamoya; mRS = modified Rankin Scale; PCA = posterior cerebral artery.
FunakiTFushimiYTakahashiJCTakagiYArakiYYoshidaK: Visualization of periventricular collaterals in moyamoya disease with flow-sensitive black-blood magnetic resonance angiography: preliminary experience. Neurol Med Chir (Tokyo)55:204–2092015
FunakiTTakahashiJCHoukinKKurodaSTakeuchiSFujimuraM: Angiographic features of hemorrhagic moyamoya disease with high recurrence risk: a supplementary analysis of the Japan Adult Moyamoya Trial. J Neurosurg[epub ahead of print April 14 2017. DOI: 10.3171/2016.11.JNS161650]]
FunakiTTakahashiJCTakagiYYoshidaKArakiYKikuchiT: Impact of posterior cerebral artery involvement on long-term clinical and social outcome of pediatric moyamoya disease. J Neurosurg Pediatr12:626–6322013
IrikuraKMiyasakaYKurataATanakaRFujiiKYadaK: A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien)138:1282–12861996
LiuPLiuAHHanCChenCLvXLLiDS: Difference in angiographic characteristics between hemorrhagic and nonhemorrhagic hemispheres associated with hemorrhage risk of moyamoya disease in adults: a self-controlled study. World Neurosurg95:348–3562016
LiuWZhuSWangXYueXZhouZWangH: Evaluation of angiographic changes of the anterior choroidal and posterior communicating arteries for predicting cerebrovascular lesions in adult moyamoya disease. J Clin Neurosci18:374–3782011
MiyamotoSYoshimotoTHashimotoNOkadaYTsujiITominagaT: Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease: results of the Japan Adult Moyamoya Trial. Stroke45:1415–14212014
MoriokaMHamadaJKawanoTTodakaTYanoSKaiY: Angiographic dilatation and branch extension of the anterior choroidal and posterior communicating arteries are predictors of hemorrhage in adult moyamoya patients. Stroke34:90–952003
QinYOgawaTFujiiSShinoharaYKitaoSMiyoshiF: High incidence of asymptomatic cerebral microbleeds in patients with hemorrhagic onset-type moyamoya disease: a phase-sensitive MRI study and meta-analysis. Acta Radiol56:329–3382015
YamadaSOkiKItohYKurodaSHoukinKTominagaT: Effects of surgery and antiplatelet therapy in ten-year follow-up from the Registry Study of Research Committee on Moyamoya Disease in Japan. J Stroke Cerebrovasc Dis25:340–3492016